OXFORD NANOPORE TECHNOLOGIES PLC financials
OXFORD NANOPORE TECHNOLOGIES PLC
213800IRWQ2Q6M2CDW55 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | £223.9M | £183.2M |
| Cost of sales | £92.6M | £77.8M |
| Gross profit | £131.3M | £105.4M |
| Operating profit (EBIT) | -£155.3M | -£152.3M |
| Finance costs | £2.8M | £3.6M |
| Profit before tax | -£139.9M | -£140.0M |
| Income tax expense | £5.3M | £6.2M |
| Profit for the year | -£145.2M | -£146.2M |
| Total comprehensive income | -£149.2M | -£144.7M |
| Cash flow statement | ||
| Net cash from operating activities | -£70.6M | -£109.9M |
| Net cash from investing activities | £56.3M | £15.0M |
| Purchase of PP&E (capex) | £3.5M | £13.9M |
| Purchase of intangibles | £49.9M | £0 |
| Net cash from financing activities | -£2.1M | £73.6M |
| Lease liability payments | £5.8M | £4.7M |
| Net change in cash | -£16.4M | -£21.3M |
| Balance sheet | ||
| Total assets | £622.5M | £742.0M |
| Non-current assets | £202.5M | £221.9M |
| Property, plant & equipment | £61.9M | £66.3M |
| Right-of-use assets | £30.9M | £34.9M |
| Current assets | £420.0M | £520.1M |
| Inventories | £81.5M | £99.5M |
| Trade & other receivables | £72.4M | £62.7M |
| Cash & equivalents | £181.1M | £199.5M |
| Total equity | £463.3M | £586.3M |
| Non-current liabilities | £41.2M | £44.2M |
| Lease liabilities (non-current) | £36.3M | £40.6M |
| Current liabilities | £118.0M | £111.5M |
| Lease liabilities (current) | £5.2M | £5.4M |
| Trade & other payables | £108.9M | £102.3M |
| Derived metrics | ||
| Free cash flow | -£74.1M | -£123.8M |
| Operating margin | -69.4% | -83.1% |
| Net margin | -64.9% | -79.8% |
| Return on equity | -31.3% | -24.9% |
| Cash conversion ratio | 0.49× | 0.75× |
| Capex coverage | -20.17× | -7.91× |
| Other reported items | ||
| Cash Outflow For Leases | £2.9M | £2.6M |
| Current Provisions | £3.9M | £3.8M |
| Current Tax Assets Current | £300.0K | £1.2M |
| Deferred Tax Assets | £2.7M | £2.6M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -£2.0M | £300.0K |
| Finance Income | £11.8M | £14.8M |
| Gains Losses On Exchange Differences On Translation Net of Tax | £1.3M | -£600.0K |
| Gains Losses On Financial Assets Measured At Fair Value Through Other Comprehensive Income Net of Tax | £3.1M | £4.6M |
| Increase Decrease Through Sharebased Payment Transactions | £19.4M | £6.0M |
| Increase Decrease Through Transactions With Owners | £26.2M | £87.1M |
| Intangible Assets Other Than Goodwill | £55.8M | £43.8M |
| Interest Received Classified As Investing Activities | £7.8M | £9.5M |
| Issue of Equity | £6.7M | £83.4M |
| Issued Capital | £100.0K | £100.0K |
| Liabilities | £159.2M | £155.7M |
| Net Assets Liabilities | £463.3M | £586.3M |
| Noncurrent Provisions | £4.4M | £3.4M |
| Other Assets | £51.2M | £74.3M |
| Other Comprehensive Income | -£4.0M | £1.5M |
| Other Comprehensive Income Net of Tax Financial Assets Measured At Fair Value Through Other Comprehensive Income | -£5.1M | £2.6M |
| Other Current Financial Assets | £74.2M | £138.8M |
| Other Gains Losses | £6.4M | £1.1M |
| Payments For Share Issue Costs | £100.0K | £2.3M |
| Proceeds From Issuing Shares | £6.7M | £83.2M |
| Proceeds From Other Longterm Assets Classified As Investing Activities | £144.1M | £54.1M |
| Reclassification Adjustments On Exchange Differences On Translation Net of Tax | £200.0K | £500.0K |
| Reclassification Adjustments On Financial Assets Measured At Fair Value Through Other Comprehensive Income Net of Tax | £8.2M | £2.0M |
| Research and Development Expense | £97.7M | £98.9M |
| Reserve of Exchange Differences On Translation | -£900.0K | -£700.0K |
| Retained Earnings | -£550.9M | -£401.9M |
| Selling General and Administrative Expense | £188.9M | £158.8M |
| Share Issue Related Cost | — | £2.3M |
| Share Premium | £786.4M | £779.7M |
Every line item above is a fact tagged in OXFORD NANOPORE TECHNOLOGIES PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (GBP), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.